Is SRZN research on Rallies investment advice?

No. Rallies provides research, data, and educational context for SRZN. It does not provide personalized investment advice.

SRZN (Surrozen, Inc. Common) Stock Analysis - Financials

Surrozen, Inc. Common (SRZN) is a publicly traded Healthcare sector company. As of November 6, 2026, SRZN trades at $30.95 with a market cap of $340.85M and a P/E ratio of -0.72. SRZN moved +6.31% today. Year to date, SRZN is +62.03%; over the trailing twelve months it is +147.59%. Its 52-week range spans $5.90 to $37.83. Analyst consensus is strong buy with an average price target of $47.50. Rallies surfaces SRZN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are SRZN's key financials?

SRZN financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. SRZN recently traded at $30.95. Market cap is $340.85M. P/E ratio is -0.72. Revenue is $11.51M.

SRZN Key Metrics

Key financial metrics for SRZN
Metric	Value
Price	$30.95
Market Cap	$340.85M
P/E Ratio	-0.72
EPS	$-41.14
Dividend Yield	0.00%
52-Week High	$37.83
52-Week Low	$5.90
Volume	129.27K
Avg Volume	0
Revenue (TTM)	$11.51M
Net Income	$-332.13M
Gross Margin	0.00%

SRZN Analyst Consensus

6 analysts cover SRZN: 0 strong buy, 6 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $47.50.

Common questions about SRZN

What are SRZN's key financials?: SRZN financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. SRZN recently traded at $30.95. Market cap is $340.85M. P/E ratio is -0.72. Revenue is $11.51M.
Is SRZN research on Rallies investment advice?: No. Rallies provides research, data, and educational context for SRZN. It does not provide personalized investment advice.